Notice2026-03095
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for Quick Turnaround Testing of Communication Effectiveness
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 18, 2026
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 32 (Wednesday, February 18, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 32 (Wednesday, February 18, 2026)]
[Notices]
[Pages 7503-7504]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-03095]
[[Page 7503]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2025-N-0615]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Generic Clearance for
Quick Turnaround Testing of Communication Effectiveness
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Submit written comments (including recommendations) on the
collection of information by March 20, 2026.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be submitted to <a href="https://www.reginfo.gov/public/do/PRAMain">https://www.reginfo.gov/public/do/PRAMain</a>. Find this particular information
collection by selecting ``Currently under Review--Open for Public
Comments'' or by using the search function. The OMB control number for
this information collection is 0910-0876. Also include the FDA docket
number found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Christopher Colburn, Office of
Operations, Food and Drug Administration, Three White Flint North, 10A-
12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8758,
<a href="/cdn-cgi/l/email-protection#b6e6e4f7e5c2d7d0d0f6d0d2d798dedec598d1d9c0"><span class="__cf_email__" data-cfemail="d383819280a7b2b5b593b5b7b2fdbbbba0fdb4bca5">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Generic Clearance for Quick Turnaround Testing of Communication
Effectiveness
OMB Control Number 0910-0876--Extension
The FDA Food Safety Modernization Act (FSMA) (Pub. L. 111-353)
enables FDA to better protect public health by helping to ensure the
safety and security of the food supply. It enables FDA to focus more on
preventing food safety problems rather than relying primarily on
reacting to problems after they occur. FSMA recognizes the important
role consumers and stakeholders play in ensuring the safety of the food
supply, which helps ensure that suppliers produce food that meets U.S.
safety standards. Section 1003(d)(2) of the FD&C Act (21 U.S.C.
393(d)(2)) authorizes FDA to conduct food research and educational and
public information programs relating to the safety of the nation's food
supply. One way the FDA supports these programs is through the use of
this collection of information.
This notice requests extension of OMB approval of the FDA
information collection for a generic clearance that allows FDA to
occasionally communicate with consumers and other stakeholders about
immediate health issues which could affect public health and safety.
This collection of information allows the use of fast-track methods of
communication such as quick turnaround surveys, focus groups, and in-
depth interviews collected from consumers and other stakeholders to
communicate FDA issues of immediate and important public health
significance. We plan on using these methods of communication to
collect vital public health and safety information. FDA plans to use
the data collected under this generic clearance to test consumer or
other stakeholder reaction to communications, advisories, and other
educational messages under development or review when there are urgent
public health matters requiring the dissemination of FDA
communications. The tests will allow FDA to better understand
consumers' responses, including behavior, knowledge, beliefs,
perceptions, and attitudes to topics and concepts included in the
communications. The data will not be directly used for the purposes of
making regulatory or other policy decisions.
For example, these methods of communication might be used when
there is a foodborne illness outbreak, food recall, or other situation
requiring expedited FDA food, dietary supplement, infant formula, or
animal food or feed communications. So that FDA may better protect the
public health, the Agency needs quick turnaround information provided
by this collection of information to help ensure its messaging has
reached the target audience, has been effective, and, if needed, to
update its communications during these events. FDA has used this
collection in the past three years by conducting quick turnaround
surveys measuring communication effectiveness for the 2023 Salmonella
Infantis Flour Recall, 2023 Hepatitis A Virus Infections/Frozen
strawberry recall, and 2023 applesauce pouches recall. We also
conducted food recall focus groups. This information gathered from
these surveys and focus groups helped us understand how consumers and
the public react to FDA communications messages and become aware of
foodborne illness outbreaks and food recalls.
FDA will only submit a collection for approval under this generic
clearance if it meets the following conditions:
<bullet> The collections are voluntary;
<bullet> The collections are low burden for participants (based on
considerations of total burden hours, total number of participants, or
burden hours per respondent) and are low cost for both the participants
and the Federal Government;
<bullet> The collections are noncontroversial;
<bullet> Personally identifiable information is collected by the
contractor for their benefit only to the extent necessary, is not
shared with FDA, and is not retained; and
<bullet> Information gathered will not be used for substantially
informing influential policy decisions.
If these conditions are not met, FDA will submit an information
collection request to OMB for approval through the normal PRA process.
To obtain approval for a collection that meets the conditions of this
generic clearance, an abbreviated supporting statement will be
submitted to OMB along with supporting documentation (e.g., a copy of
the survey, focus group or interview guide, and stimuli).
Respondents to this collection of information include a wide range
of consumers and other FDA stakeholders such as producers and
manufacturers of FDA-regulated food, infant formula, dietary
supplements, and animal food and feed. Participation will be voluntary.
In the Federal Register of July 3, 2025 (90 FR 29565), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
FDA estimates the burden of this collection of information as
follows:
[[Page 7504]]
Table 1--Estimated Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
Number of Total
Survey type Number of responses per annual Average burden per Total hours
respondents respondent responses response
----------------------------------------------------------------------------------------------------------------
In-depth Interviews, 45 1 45 0.083 (5 minutes)....... 4
Cognitive Interviews
Screener.
In-depth Interviews, 9 1 9 1....................... 9
Cognitive Interviews.
In-depth Interviews Screener 300 1 300 0.083 (5 minutes)....... 25
In-depth Interviews......... 60 1 60 1....................... 60
Survey Cognitive Interviews 45 1 45 0.083 (5 minutes)....... 4
Screener.
Survey Cognitive Interviews. 9 1 9 1....................... 9
Pretest survey screener..... 1,500 1 1,500 0.083 (5 minutes)....... 124
Pretest survey.............. 300 1 300 0.25 (15 minutes)....... 76
Self-Administered Surveys-- 7,500 1 7,500 0.083 (5 minutes)....... 622.5
Study Screener.
Self-Administered Surveys... 1,500 1 1,500 0.25 (15 minutes)....... 375
Focus Group/Small Group, 180 1 180 0.083 (5 minutes)....... 15
Cognitive Groups Screener.
Focus Group/Small Group, 60 1 60 1.5 (90 minutes)........ 90
Cognitive Groups.
Focus Group/Small Group 720 1 720 0.083 (5 minutes)....... 60
Participant Screening.
Focus Group/Small Group 240 1 240 1.5 (90 minutes)........ 360
Discussion.
-----------------------------------------------------------------------------------
Total................... ............ .............. .......... ........................ 1,833.5
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
information.
Since our initial request for continued approval, we have
reevaluated actual usage of individual clearance requests. Accordingly,
we have adjusted our estimate downward.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-03095 Filed 2-17-26; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 18, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.